Study of ABBV-932 with itraconazole for bipolar disorder
Treatments studied
Part of Mental health clinical trials.
This study tests an investigational drug called ABBV-932 in people with bipolar disorder. It looks at how the drug moves through the body when taken with another medication (itraconazole) and checks for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old (implied by BMI range, but not explicitly stated; assume adult).
- Your body mass index (BMI) is between 18.0 and 38.0.
- You have been diagnosed with bipolar I or II disorder.
- You have not had a major mood episode or been hospitalized for psychiatric reasons in the past 3 months.
- You have not had suicidal thoughts or behaviors recently (within the past year for thoughts, 2 years for behaviors).
- You have not taken certain psychiatric medications (like antipsychotics, antidepressants, or mood stabilizers) in the past 14 days, except for a small dose of lorazepam (up to 2 mg/day).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called brenipatide for people with bipolar I or II disorder. It aims to see if the drug can help manage mood episodes when added to your current stable medications.
This trial tests the safety of a new oral drug, ABBV-1042, in healthy adults. It helps researchers understand how the drug moves through the body and what side effects may occur.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This trial tests an experimental pill (ABB-932) for people with bipolar I or II disorder who are currently in a depressive episode. The goal is to see if the drug is safe and helps improve mood.
This trial tests an oral medicine called ABBV-932 when added to current antidepressant therapy for people with generalized anxiety disorder (GAD) who still have symptoms. It aims to see if the combination can improve anxiety and reduce side effects.
This trial studies a new drug called ABBV-859 in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Hear when a new Bipolar Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.